{"href":"https://api.simplecast.com/oembed?url=https%3A%2F%2Fa16z.simplecast.com%2Fepisodes%2Fa16z-podcast-the-economics-of-expensive-medicines-mYTE95RD","width":444,"version":"1.0","type":"rich","title":"a16z Podcast: The Economics of Expensive Medicines","thumbnail_width":300,"thumbnail_url":"https://image.simplecastcdn.com/images/0d97354a-306b-45f5-bf26-a8d81eef47ec/ed2664df-9371-438e-8baf-dd2ee0fdde87/thea16zshow-podcastcoverart-3000x3000.jpg","thumbnail_height":300,"provider_url":"https://simplecast.com","provider_name":"Simplecast","html":"<iframe src=\"https://player.simplecast.com/2e5b201a-9c6e-4b23-991e-19804acd9ccc\" height=\"200\" width=\"100%\" title=\"a16z Podcast: The Economics of Expensive Medicines\" frameborder=\"0\" scrolling=\"no\"></iframe>","height":200,"description":"with Andrew Lo (@AndrewWLo) and Jorge Conde (@JorgeCondeBio)\n\nThe advent of new gene and cell therapies are beginning to approach that holy grail of medicine—that of a possible cure. But they are also more expensive than any medicines ever sold befor..."}